Internal Medicine, Hematology · Springfield, MA
NPI
1578530804
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3350 Main St
Springfield, MA, 01107
Phone (413) 794-9338
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
858 services
Medicare patients, 2024
425
Average age 75
Drug cost, 2024
$10.6M
1,169 prescriptions
Company payments, 2025
$46.09
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chandravathi Loke was code 99214 (office e&m - established), 277 times for 228 patients. In total Chandravathi Loke billed 858 services in 15 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 277 | 228 | $68.74 | $19K |
| 99215 Office E&M - Established | Facility | 262 | 166 | $106.43 | $28K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 126 | 111 | $12.82 | $1,615 |
| 99233 Hospital E&M - Subsequent | Facility | 63 | 23 | $93.03 | $5,861 |
| 99223 Hospital E&M - Initial | Facility | 39 | 39 | $136.10 | $5,308 |
| 99205 Office E&M - New | Facility | 25 | 25 | $139.08 | $3,477 |
| 38222 Other Organ Systems | Facility | 19 | 19 | $58.84 | $1,118 |
By year: 2022 $73K for 805 services; 2023 $69K for 775 services; 2024 $68K for 858 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chandravathi Loke prescribed most often to Medicare patients was Lenalidomide, with 131 prescriptions and refills. In total Chandravathi Loke wrote 1,169 Medicare prescriptions that cost $10.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenalidomide Generic | 131 | 131 | 19 | $1.6M |
| Hydroxyurea Generic | 95 | 221 | 29 | $2,811 |
| Pomalyst Pomalidomide | 91 | 91 | 15 | $2.1M |
| Anastrozole Generic | 81 | 213 | 29 | $1,923 |
| Revlimid Lenalidomide | 73 | 73 | 21 | $1.3M |
| Ninlaro Ixazomib Citrate | 55 | 55 | Under 11 | $689K |
| Brukinsa Zanubrutinib | 55 | 55 | Under 11 | $748K |
| Ibrance Palbociclib | 52 | 52 | Under 11 | $755K |
| Venclexta Venetoclax | 47 | 49 | 13 | $241K |
| Calquence Acalabrutinib Maleate | 46 | 46 | Under 11 | $697K |
| Imatinib Mesylate Generic | 42 | 42 | Under 11 | $3,747 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 67 | 11 | $113 |
| Jakafi Ruxolitinib Phosphate | 32 | 32 | Under 11 | $503K |
| Imbruvica Ibrutinib | 31 | 31 | Under 11 | $333K |
| Prednisone Generic | 26 | 28 | Under 11 | $65.12 |
Brand drugs: 597 claims; generic drugs: 572 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chandravathi Loke $46.09 ($46.09 in general payments such as food, travel and fees) from 1 company. The largest payer was Alnylam Pharmaceuticals Inc. with $46.09.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $46.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.